print PRINT

SCIENCE > Health

Another Japanese drug under consideration for COVID-19 treatment

  • May 7, 2020
  • , Mainichi digital
  • JMH Summary

Mainichi reported online on an announcement made by Kitasato University yesterday that it will launch clinical trials for coronavirus treatment using a drug that one of its microbiologists helped develop four decades ago. Economic and Fiscal Policy Minister Nishimura, who is in charge of the GOJ’s response to the coronavirus outbreak, visited the college on Wednesday and met with school administrators, including Professor Emeritus Omura, who won the Nobel Prize in 2015 for developing the drug Ivermectin, which has been used to treat river blindness and elephantiasis. As a U.S. college has reported that the medicine used for treating these diseases caused by parasitic worms was apparently found to be effective in treating the new pathogen, the school officials informed the minister of their plan to start clinical trials of Ivermectin for COVID-19 patients.

  • Ambassador
  • Ukraine
  • COVID-19
  • Trending Japan